PharmaDeals Review features:
PharmaDeals analyses specific deals and examines trends and developments within deal making in different technology and therapy areas. It also asesses data from the PharmaDeals v4 database, as well as many other sources of information and the in-house knowledge base available to our expert team of writers.
- Deal trackers articles where late phase and recently launched products are explored from the perspective of the deals done to bring them through development, offering insight into the complex alliance history of individual drugs
- Deal analysis and opinion from our expert team of writers
- Business commentary – The Publisher and CEO Dr Fintan Walton comments on topical industry issues and how they may impact on deal making
- Feature articles from the industry’s thought leaders offering in-depth analysis of the key developments within deal making
- Global companies' deal watch
- Conference calendar – specially selected conferences
- Yearly analysis: Summary of the year and comment prospective, future trends
In addition, your subscription includes the entire PharmaDeals Review Article Archive – hundreds of articles all links to specific deals recorded in the PharmaDeals v4 database
Subscribers to PharmaDeals v4, receive PharmaDeals Review at no additional cost.